The Bloodwise logo. Bloodwise appears in black text against a white background
Posted by

Departure of Pelham Allen as Chair of the Board of Trustees

The Bloodwise logo. Bloodwise appears in black text against a white background
Posted by
08 Jun 2017

Pelham Allen, Chair of the Board of Trustees, has taken the decision to step down from his position at Bloodwise due to health concerns.

Pelham has held the role of Chair of the Board of Trustees at Bloodwise for four years. During this time he has led the charity through a period of change and development, and his skills and experience have been a huge asset to the organisation.  Under Pelham’s tenure Bloodwise invested more than ever in world leading clinical research whilst broadening Bloodwise’s remit to help and support those living with and beyond blood cancer. 

The last 12 months have been a challenging time for Bloodwise, and Pelham has been instrumental in stabilising the charity and setting us on a clear course forward, most recently leading on the recruitment of our new CEO, Gemma Peters. We are incredibly grateful for Pelham’s dedication and commitment to Bloodwise. 

The process for recruiting a new Chair will begin immediately, and will be undertaken by the Board of Trustees.  In the intervening period, Jeremy Bird, currently Vice Chair, will become interim Chair.  He will be supported by current trustee Charlie Metcalfe, who will take the role of Vice Chair during this period.

Jeremy and Charlie have both been involved with Bloodwise for many years. 

Jeremy began his association with Bloodwise in 2007 when he joined the Finance and General Purpose Committee as an advisor before becoming a trustee.  At the time, he was Managing Director of Wickes, who were at the start of their 10 year, £5m association with the charity.  He has been Vice Chair for four years, and in addition chairs the Governance Committee as well as sitting on both the Remuneration & Appointments Committee and the Audit and Risk Committee.

Charlie became a trustee six years ago, having previously been an advisor to the charity’s Investment Committee for two years.  He now chairs the Investment Committee.  He was originally introduced to the charity by Alastair Campbell after a death in the family from Acute Myeloid Leukaemia.